The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts).
 
Ibrahim Halil Sahin
No Relationships to Disclose
 
Subir Goyal
No Relationships to Disclose
 
Yoanna S Pumpalova
No Relationships to Disclose
 
Mohamad Bassam Sonbol
No Relationships to Disclose
 
Satya Das
Honoraria - Lexicon; Lexicon; Lexicon; Lexicon; Medsphere; Medsphere; Medsphere; Medsphere; Targeted Oncology; Targeted Oncology; Targeted Oncology; Targeted Oncology
 
Sigurdis Haraldsdottir
No Relationships to Disclose
 
Zhengjia Chen
No Relationships to Disclose
 
Mehmet Akce
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen
Research Funding - Bristol-Myers Squibb-Ono Pharmaceutical (Inst); Bristol-Myers Squibb-Ono Pharmaceutical (Inst); Bristol-Myers Squibb-Ono Pharmaceutical (Inst); Bristol-Myers Squibb-Ono Pharmaceutical (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); Polaris (Inst); RedHill Biopharma (Inst); RedHill Biopharma (Inst); RedHill Biopharma (Inst); RedHill Biopharma (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Xencor (Inst); Xencor (Inst); Xencor (Inst); Xencor (Inst)
 
Olatunji B. Alese
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Conjupro Biotherapeutics; Conjupro Biotherapeutics; Conjupro Biotherapeutics; Conjupro Biotherapeutics; Exelixis; Exelixis; Exelixis; Exelixis; Ipsen; Ipsen; Ipsen; Ipsen
Research Funding - Acetylon Pharmaceuticals (Inst); Acetylon Pharmaceuticals (Inst); Acetylon Pharmaceuticals (Inst); Acetylon Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Exelixis; Exelixis; Exelixis; Exelixis
 
Walid Labib Shaib
Research Funding - ArQule (Inst); ArQule (Inst); ArQule (Inst); ArQule (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst)
 
Daniel H. Ahn
Consulting or Advisory Role - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Cardinal Health; Cardinal Health; Cardinal Health; Cardinal Health; Celltrion (I); Celltrion (I); Celltrion (I); Celltrion (I); Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Lexicon; Lexicon; Lexicon; Lexicon
 
Kristen Keon Ciombor
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Research to Practice; Research to Practice; Research to Practice; Research to Practice; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Nucana (Inst); Nucana (Inst); Nucana (Inst); Nucana (Inst); Onyx (Inst); Onyx (Inst); Onyx (Inst); Onyx (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst)
 
Jordan Berlin
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer Health; Bayer Health; Bayer Health; Bayer Health; Celgene; Celgene; Celgene; Celgene; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; ipsen; ipsen; ipsen; ipsen; lsk biopharma; lsk biopharma; lsk biopharma; lsk biopharma; qed therapeutics; qed therapeutics; qed therapeutics; qed therapeutics; Seagen; Seagen; Seagen; Seagen
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Loxo (Inst); Loxo (Inst); Loxo (Inst); Loxo (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); pfizer (Inst); pfizer (Inst); pfizer (Inst); pfizer (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); PsiOxus Therapeutics (Inst); PsiOxus Therapeutics (Inst); PsiOxus Therapeutics (Inst); PsiOxus Therapeutics (Inst); Symphogen (Inst); Symphogen (Inst); Symphogen (Inst); Symphogen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; Bayer; Bayer; Bayer; Bayer; boston Biomedical; boston Biomedical; boston Biomedical; boston Biomedical; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Seagen; Seagen; Seagen; Seagen
Other Relationship - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; Amgen (Inst); Amgen (Inst); AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Immuneering; Immuneering; Immuneering; Immuneering; Imugene; Imugene; Imugene; Imugene; Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly; Lilly; Lilly; Lilly; Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); NCCN; NCCN; NCCN; NCCN; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Regeneron; Regeneron; Regeneron; Regeneron; Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - NCCN; NCCN; NCCN; NCCN; NCI; NCI; NCI; NCI; Oncolytics; Oncolytics; Oncolytics; Oncolytics
Other Relationship - ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; ARMO BioSciences; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Exelixis; Exelixis; Exelixis; Exelixis; Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Polaris; Polaris; Polaris; Polaris; Sillajen; Sillajen; Sillajen; Sillajen
 
Amber Draper
Honoraria - Wellstat Therapeutics; Wellstat Therapeutics; Wellstat Therapeutics; Wellstat Therapeutics
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma
 
Gregory B. Lesinski
No Relationships to Disclose
 
Bassel F. El-Rayes
Honoraria - Bayer; Bayer; Bayer; Bayer; Lexicon; Lexicon; Lexicon; Lexicon; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; BTG; BTG; BTG; BTG; Loxo; Loxo; Loxo; Loxo; Merrimack; Merrimack; Merrimack; Merrimack; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions; RTI Health Solutions
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lexicon; Lexicon; Lexicon; Lexicon
Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AVEO (Inst); AVEO (Inst); AVEO (Inst); AVEO (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Cleave Biosciences (Inst); Cleave Biosciences (Inst); Cleave Biosciences (Inst); Cleave Biosciences (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Hoosier Cancer Research Network (Inst); Hoosier Cancer Research Network (Inst); Hoosier Cancer Research Network (Inst); ICON Clinical Research (Inst); ICON Clinical Research (Inst); ICON Clinical Research (Inst); ICON Clinical Research (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); PPD (Inst); PPD (Inst); PPD (Inst); PPD (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Xencor (Inst); Xencor (Inst); Xencor (Inst); Xencor (Inst)
Other Relationship - ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; ERYTECH Pharma; Exelixis; Exelixis; Exelixis; Exelixis
 
Christina Wu
Research Funding - Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Lycera (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Symphogen (Inst); Symphogen (Inst); Symphogen (Inst); Symphogen (Inst); Vaccinex (Inst); Vaccinex (Inst); Vaccinex (Inst); Vaccinex (Inst)